1-3 of 3
Dakota Jenneman
Close
Sort by
Journal Articles

High Ki67 Index Is Associated with Shorter Progression Free Survival in Follicular Lymphoma Patients Treated with Frontline Immunochemotherapy

Jianmin Han, Chad M McCall, Scott Isom, Wesley Smith, Dakota Jenneman, Stephanie Begley, Rupali Bose, Mary Beth Seegars, Eric D. Hsi, Nilanjan Ghosh
Journal: Blood
Blood (2023) 142 (Supplement 1): 4385.
https://doi.org/10.1182/blood-2023-180106
Published: 2023
Journal Articles

Chemotherapy Based Salvage Regimens Are Associated with Poor Outcomes in Refractory Classical Hodgkin Lymphoma

Ashley Rose, MD, Dakota Jenneman, MD, Leidy Isenalumhe, MD, Julio C. Chavez, MD, Bijal Shah, MD, Lubomir Sokol, MD PhD, Javier Pinilla Ibarz, MD PhD, Celeste Bello, MD, Hayder Saeed, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-138815
Published: 2020
Journal Articles

Outcomes Following Intolerance to Tacrolimus/Sirolimus for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant

Sayeef Mirza, MDMPH, Ankita Tandon, DO, Dakota Jenneman, MD, Shu Cao, MD, Ambuj Kumar, MD MPH, Michelle R. Kidd, PharmD, Farhad Khimani, MD, Asmita Mishra, MD, Hien D. Liu, MD, Taiga Nishihori, MD, Lia Perez, MD, Nelli Bejanyan, MD, Joseph Pidala, MD, Michael Nieder, MD, Hany Elmariah, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5673.
https://doi.org/10.1182/blood-2019-127370
Published: 2019